Home / Companies / Avstera Therapeutics Corp / Trends
Avstera Therapeutics Corp H-1B trends
Quarterly LCA aggregate trend points for Avstera Therapeutics Corp. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
Avstera Therapeutics Corp recorded 1 H-1B LCA filings in 2023 Q3.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 1 | 1 | 1 | $70,000 | $68,848 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Avstera Therapeutics Corp changed over time?
- Avstera Therapeutics Corp recorded 1 H-1B LCA filings in 2023 Q3. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=avstera+therapeutics+corp&metric=lca_countJSON